Business Context and Reporting Period
Company: Greatbatch, Inc. (Note: Metadata referenced Integer Holdings Corp, but filing text identifies Greatbatch, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: August 27, 2015
Event: Entry into a Material Definitive Agreement for the acquisition of Lake Region Medical Holdings, Inc. ("Lake Region").
Key Financial Metrics and Transaction Terms
- Total Merger Consideration: Approximately $478 million in cash plus 5.1 million newly issued shares of Greatbatch common stock and options.
- Debt Assumption: Greatbatch will pay off Lake Region's outstanding net funded debt, estimated at approximately $1.0 billion.
- Financing Structure:
- $300 million Senior Secured Term Loan A facility.
- $1.0 billion Senior Secured Term Loan B facility.
- $200 million Senior Secured Revolving facility.
- Up to $400 million Senior Unsecured Bridge facility (subject to replacement with long-term debt).
- Collateral: Senior secured facilities are secured by a first-priority security interest in substantially all non-real estate assets of Greatbatch and certain subsidiaries.
Material Changes and Transaction Structure
Greatbatch, Inc. entered into an Agreement and Plan of Merger with Lake Region Medical Holdings, Inc. The transaction involves a merger of a Greatbatch subsidiary with Lake Region, with Lake Region surviving as a wholly-owned indirect subsidiary. The consideration includes a mix of cash and equity, with specific provisions for rolling over certain senior management options. The transaction is not subject to a financing condition.
Guidance, Outlook, Risks, and Contingencies
- Closing Conditions: Subject to regulatory approvals (including antitrust/Hart-Scott Rodino), NYSE listing approval for new shares, and Lake Region shareholder approval.
- Timeline: The merger must be completed by November 25, 2015, extendable to February 23, 2016, if regulatory conditions are met.
- Risks:
- Failure to obtain regulatory approvals or imposition of adverse conditions (e.g., divestitures).
- Inability to realize anticipated synergies or successfully integrate operations.
- Disruption of management attention and business relationships.
- Access to financing on reasonable terms.
- General healthcare industry risks including regulatory changes and product liability.
- Forward-Looking Statements: The filing contains forward-looking statements regarding future financial results and transaction benefits, which are subject to significant uncertainties.
Investor Verification Checklist
- Verify the final approval status of the merger by Lake Region shareholders and regulatory bodies (antitrust).
- Confirm the final terms of the long-term debt financing intended to replace the $400 million bridge facility.
- Monitor for any required divestitures imposed by antitrust authorities that could impact the combined company's value.
- Review the detailed Merger Agreement (Exhibit 2.1) for specific representations, warranties, and termination rights.
- Assess the impact of the $1.0 billion debt repayment and new debt issuance on Greatbatch's future liquidity and leverage ratios.